Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies

A Parissi-Crivelli1, J M Parissi-Crivelli, J A Girón

  • 1Centro de Investigaciones en Ciencias Microbiológicas, Instituto de Ciencias, Benemérita Autónoma Universidad de Puebla, Puebla, Mexico.

Insights

Human colostra and sera show antibodies against enteropathogenic Escherichia coli (EPEC) virulence factors. Breast milk (colostrum) and infant immune responses highlight the protective role of breastfeeding against EPEC infections.

Area of Science:

  • Immunology
  • Microbiology
  • Pediatrics

Background:

  • Enteropathogenic Escherichia coli (EPEC) is a significant cause of diarrheal disease globally.
  • Virulence factors like intimin and secreted proteins (EspA, EspB) are crucial for EPEC pathogenesis.
  • The role of maternal antibodies transferred through breast milk in protecting neonates against EPEC is of public health importance, especially in endemic regions.

Purpose of the Study:

  • To investigate the presence of antibodies against EPEC virulence factors in human colostrum and sera from Mexican mothers and their children.
  • To analyze the infant antibody response to EPEC antigens from birth to 6 months of age.

Main Methods:

  • Human colostrum and infant sera were collected at birth and 6 months.
  • Antibodies against EPEC bundle-forming pilus (BfpA) and chromosomal virulence factors (intimin, EspA, EspB) were detected.
  • Immunoglobulin A (IgA) in colostrum and Immunoglobulin G (IgG) in sera were analyzed.

Main Results:

  • A high prevalence of IgA antibodies against EPEC virulence factors (EspA, intimin, EspB, BfpA) was found in colostrum samples.
  • Infant IgG responses to EspA and intimin decreased from birth to 6 months.
  • Infant IgG responses to BfpA significantly increased from 9% at birth to 71% at 6 months.
  • Antibodies against EPEC intimin cross-reacted with intimin from enterohemorrhagic E. coli.

Conclusions:

  • EPEC virulence factors, particularly BfpA and Esps, induce an antibody response in neonates.
  • Breastfeeding plays a vital role in providing passive immunity against EPEC infections.
  • These findings support the importance of breastfeeding in preventing diarrheal diseases in regions where EPEC is endemic.

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview